Company: LASE
Filing Date: 2025-06-24
Form Type: 10-K
Source: 0001641172-25-016194
Chunk: 213

Company: Laser Photonics Corp
Filing Date: 2025-06-24
Form: 10-K
Item: Item 1
Chunk 213
---
 from using
the technology at issue on the grounds that our patent claims do not cover its technology or that the factors necessary to grant an injunction
against an infringer are not satisfied. An adverse determination of any litigation or other proceedings could put one or more of our
patents at risk of being invalidated, interpreted narrowly, or amended such that they do not cover our product candidates. Moreover,
such adverse determinations could put our patent applications at risk of not issuing or issuing with limited and potentially inadequate
scope to cover our product candidates or to prevent others from marketing similar products.

Interference,
derivation or other proceedings brought at USPTO, may be necessary to determine the priority or patentability of inventions with respect
to our patent applications or those of our licensors or potential collaborators. Litigation or USPTO proceedings brought by us may fail
or may be invoked against us by third parties. Even if we are successful, domestic or foreign litigation or USPTO or foreign patent office
proceedings may result in substantial costs and distraction to our management. We may not be able, alone or with our licensors or potential
collaborators, to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect such rights
as fully as in the United States.

27

Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation or other proceedings, there
is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings.
In addition, during this kind of litigation or proceedings, there could be public announcements of the results of hearings, motions or
other interim proceedings or developments or public access to related documents. If investors perceive these results to be negative,
the market price for our common stock could be significantly harmed.

Some
of our competitors may be able to sustain the costs of patent-related disputes, including patent litigation, more effectively than we
can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation
of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.

We
may not be able to enforce our intellectual property rights throughout the world.

Filling,
prosecuting and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive. The
requirements for patentability may differ in certain countries, particularly in developing countries. Moreover, our ability to protect
and enforce our intellectual property rights may be adversely affected by unfore